That's the discussion you have post p1a/b.
When the RC220 patent is lodged we want clinical validation in as many indications as possible - as quickly and for as little spend as possible.
Ann: Updated Strategy and Investor Presentation, page-397
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.055(3.40%) |
Mkt cap ! $276.0M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.65 | $1.54 | $114.5K | 71.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3002 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 800 | 1 |
View Market Depth
| Last trade - 12.41pm 31/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |